Third, Numerous studies have demonstrated that conventional inflammatory markers, such as the neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and C-reactive protein (CRP), possess strong prognostic predictive capabilities in cancer patients (58–63). This evidence concerns the gene CRP and cancer.